Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · IEX Real-Time Price · USD

11.59

-0.11 (-0.94%)

At close: Jul 19, 2024, 4:30 PM

11.97

+0.38 (3.28%)

Pre-market: Jul 22, 2024, 7:43 AM EDT

Y-mAbs Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	84.5	84.82	65.27	34.9	20.75	0	Upgrade
Revenue Growth (YoY)	12.62%	29.96%	87.03%	68.18%	-	-	Upgrade
Cost of Revenue	11.48	11.42	7.57	2.51	2.2	0	Upgrade
Gross Profit	73.02	73.4	57.7	32.38	18.55	0	Upgrade
Selling, General & Admin	44.03	44.86	60.94	54.57	44.79	19.51	Upgrade
Research & Development	54.07	54.22	91.57	93.25	93.7	63.49	Upgrade
Operating Expenses	98.1	99.08	152.51	147.82	138.48	83	Upgrade
Operating Income	-25.08	-25.67	-94.81	-115.43	-119.94	-83	Upgrade
Interest Expense / Income	-4.13	-4.81	0.76	1.85	-0.6	-1.98	Upgrade
Other Expense / Income	-	-	-	-62.01	-	-	Upgrade
Pretax Income	-20.95	-20.87	-95.57	-55.28	-119.34	-81.03	Upgrade
Income Tax	0.72	0.56	0	0	0	0	Upgrade
Net Income	-21.67	-21.43	-95.57	-55.28	-119.34	-81.03	Upgrade
Shares Outstanding (Basic)	44	44	44	43	40	35	Upgrade
Shares Outstanding (Diluted)	44	44	44	43	40	35	Upgrade
Shares Change	0.25%	-0.13%	1.21%	7.64%	14.03%	22.28%	Upgrade
EPS (Basic)	-0.49	-0.49	-2.19	-1.28	-2.97	-2.30	Upgrade
EPS (Diluted)	-0.49	-0.49	-2.19	-1.28	-2.97	-2.30	Upgrade
Free Cash Flow	-17.59	-27.23	-75.92	-41.21	-91.41	-75.46	Upgrade
Free Cash Flow Per Share	-0.40	-0.62	-1.74	-0.95	-2.28	-2.15	Upgrade
Gross Margin	86.41%	86.54%	88.41%	92.80%	89.38%	-	Upgrade
Operating Margin	-29.68%	-30.27%	-145.27%	-330.78%	-578.00%	-	Upgrade
Profit Margin	-25.64%	-25.26%	-146.43%	-158.39%	-575.12%	-	Upgrade
Free Cash Flow Margin	-20.81%	-32.11%	-116.32%	-118.10%	-440.51%	-	Upgrade
EBITDA	-24.37	-24.94	-93.97	-52.64	-119.54	-82.84	Upgrade
EBITDA Margin	-28.84%	-29.40%	-143.98%	-150.85%	-576.09%	-	Upgrade
Depreciation & Amortization	0.71	0.74	0.84	0.78	0.4	0.17	Upgrade
EBIT	-25.08	-25.67	-94.81	-53.42	-119.94	-83	Upgrade
EBIT Margin	-29.68%	-30.27%	-145.27%	-153.09%	-578.00%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).